RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $284
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on HCA Healthcare (NYSE:HCA), but lowered the price target from $315 to $284.
October 25, 2023 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HCA Healthcare's price target has been lowered by RBC Capital from $315 to $284, although the 'Outperform' rating is maintained.
The lowering of the price target by RBC Capital could potentially create a negative sentiment among investors, which might put downward pressure on the stock price. However, the maintained 'Outperform' rating indicates that the analyst still sees potential upside, which could counterbalance the negative sentiment to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100